{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:17:09Z","timestamp":1788481029861,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["17ZR1403100"],"award-info":[{"award-number":["17ZR1403100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is a common endocrine disease of the female reproductive system that seriously affects women\u2019s health. Berberine (BBR) has many pharmacological properties and is used as an insulin sensitizer. This study aimed to investigate the effect of BBR on PCOS and explore its related mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Forty-two rats were randomly divided into the following six groups (<jats:italic>n<\/jats:italic>\u2009=\u20097 per group): control, control + BBR, PCOS-normal diet (ND), PCOS-ND\u2009+\u2009BBR, PCOS-high-fat diet (HFD), and PCOS-HFD\u2009+\u2009BBR. The PCOS rat models were established by injecting rats with dehydroepiandrosterone. Further, the rats were gavaged with BBR (150\u2009mg\/kg\/d) for 6 weeks. Then, the body weight, HOMA-IR, and testosterone levels of all rats were determined. Cell apoptosis of ovary granulosa cells was determined by a TUNEL assay kit. Real-time quantification PCR (RT-qPCR) and western blotting were utilized to evaluate the expression of <jats:italic>TLR4<\/jats:italic>, <jats:italic>LYN<\/jats:italic>, <jats:italic>PI3K<\/jats:italic>, <jats:italic>Akt<\/jats:italic>, <jats:italic>NF-kB<\/jats:italic>, <jats:italic>TNF-\u03b1<\/jats:italic>, <jats:italic>IL-1<\/jats:italic>, <jats:italic>IL-6<\/jats:italic>, and <jats:italic>caspase-3<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BBR reduced the levels of insulin resistance and testosterone in PCOS rats. Additionally, the cell apoptosis rate increased significantly in PCOS rats (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) and decreased after BBR treatment (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The results of RT-qPCR and western blotting showed that the expression levels of <jats:italic>TLR4<\/jats:italic>, <jats:italic>LYN<\/jats:italic>, <jats:italic>PI3K<\/jats:italic>, <jats:italic>Akt<\/jats:italic>, <jats:italic>NF-kB<\/jats:italic>, <jats:italic>TNF-\u03b1<\/jats:italic>, <jats:italic>IL-1<\/jats:italic>, <jats:italic>IL-6<\/jats:italic>, and <jats:italic>caspase-3<\/jats:italic> significantly increased in PCOS rats, while BBR suppressed their expression levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>BBR may relieve PCOS pathology and IR values by inhibiting cell apoptosis and by regulating the expression levels of <jats:italic>TLR4<\/jats:italic>, <jats:italic>LYN<\/jats:italic>, <jats:italic>PI3K<\/jats:italic>, <jats:italic>Akt<\/jats:italic>, <jats:italic>NF-kB<\/jats:italic>, <jats:italic>TNF-\u03b1<\/jats:italic>, <jats:italic>IL-1<\/jats:italic>, <jats:italic>IL-6<\/jats:italic>, and <jats:italic>caspase-3<\/jats:italic>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-020-00684-y","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T02:07:00Z","timestamp":1609985220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Hao-Ran","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2195-7904","authenticated-orcid":false,"given":"Xue-Lian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"684_CR1","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.12659\/MSM.910743","volume":"24","author":"Y Chen","year":"2018","unstructured":"Chen Y, Yang T, Hao C, Zhao J. A retrospective study of Letrozole treatment prior to human chorionic gonadotropin in women with polycystic ovary syndrome undergoing in vitro fertilization at risk of ovarian Hyperstimulation syndrome. Med Sci Monitor. 2018;24:4248\u201353. https:\/\/doi.org\/10.12659\/MSM.910743.","journal-title":"Med Sci Monitor"},{"issue":"11","key":"684_CR2","doi-asserted-by":"publisher","first-page":"nzz108","DOI":"10.1093\/cdn\/nzz108","volume":"3","author":"KP Hamilton","year":"2019","unstructured":"Hamilton KP, Zelig R, Parker AR, Haggag A. Insulin resistance and serum magnesium concentrations among women with polycystic ovary syndrome. Curr Dev Nutr. 2019;3(11):nzz108. https:\/\/doi.org\/10.1093\/cdn\/nzz108.","journal-title":"Curr Dev Nutr"},{"key":"684_CR3","doi-asserted-by":"publisher","first-page":"116940","DOI":"10.1016\/j.lfs.2019.116940","volume":"236","author":"J Wang","year":"2019","unstructured":"Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940. https:\/\/doi.org\/10.1016\/j.lfs.2019.116940.","journal-title":"Life Sci"},{"key":"684_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40738-016-0029-2","volume":"2","author":"HR Harris","year":"2016","unstructured":"Harris HR, Terry KL. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract. 2016;2:14. https:\/\/doi.org\/10.1186\/s40738-016-0029-2.","journal-title":"Fertil Res Pract"},{"issue":"4","key":"684_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2337\/dc18-1738","volume":"42","author":"NS Kakoly","year":"2019","unstructured":"Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care. 2019;42(4):560\u20137. https:\/\/doi.org\/10.2337\/dc18-1738.","journal-title":"Diabetes Care"},{"issue":"8","key":"684_CR6","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/humrep\/dez104","volume":"34","author":"S Karthik","year":"2019","unstructured":"Karthik S, Vipin VP, Kapoor A, Tripathi A, Shukla M, Dabadghao P. Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome. Hum Reprod. 2019;34(8):1559\u201366. https:\/\/doi.org\/10.1093\/humrep\/dez104.","journal-title":"Hum Reprod"},{"issue":"1","key":"684_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1573402115666190531071422","volume":"16","author":"D Macut","year":"2020","unstructured":"Macut D, Mladenovic V, Bjekic-Macut J, Livadas S, Stanojlovic O, Hrncic D, Rasic-Markovic A, Milutinovic DV, Andric Z. Hypertension in polycystic ovary syndrome: novel insights. Curr Hypertens Rev. 2020;16(1):55\u201360. https:\/\/doi.org\/10.2174\/1573402115666190531071422.","journal-title":"Curr Hypertens Rev"},{"issue":"39","key":"684_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.7748\/ns.2017.e10595","volume":"31","author":"P Cunningham","year":"2017","unstructured":"Cunningham P. Pathophysiology, diagnosis and treatment of polycystic ovary syndrome. Nurs Stand. 2017;31(39):44\u201351. https:\/\/doi.org\/10.7748\/ns.2017.e10595.","journal-title":"Nurs Stand"},{"issue":"3","key":"684_CR9","doi-asserted-by":"publisher","first-page":"e91554","DOI":"10.5812\/ijem.91554","volume":"17","author":"F Ramezani Tehrani","year":"2019","unstructured":"Ramezani Tehrani F, Amiri M. Polycystic ovary syndrome in adolescents: challenges in diagnosis and treatment. Int J Endocrinol Metab. 2019;17(3):e91554. https:\/\/doi.org\/10.5812\/ijem.91554.","journal-title":"Int J Endocrinol Metab"},{"key":"684_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.12659\/MSM.912341","volume":"25","author":"Y Hong","year":"2019","unstructured":"Hong Y, Yin Y, Tan Y, Hong K, Zhou H. The Flavanone, Naringenin, modifies antioxidant and Steroidogenic enzyme activity in a rat model of Letrozole-induced polycystic ovary syndrome. Med Sci Monitor. 2019;25:395\u2013401. https:\/\/doi.org\/10.12659\/MSM.912341.","journal-title":"Med Sci Monitor"},{"issue":"5","key":"684_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/1933719116667218","volume":"24","author":"Z Wang","year":"2017","unstructured":"Wang Z, Zhai D, Zhang D, Bai L, Yao R, Yu J, Cheng W, Yu C. Quercetin decreases insulin resistance in a polycystic ovary syndrome rat model by improving inflammatory microenvironment. Reprod Sci. 2017;24(5):682\u201390. https:\/\/doi.org\/10.1177\/1933719116667218.","journal-title":"Reprod Sci"},{"issue":"17","key":"684_CR12","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2174\/1389557517666170321103139","volume":"18","author":"D Xiao","year":"2018","unstructured":"Xiao D, Liu Z, Zhang S, Zhou M, He F, Zou M, Peng J, Xie X, Liu Y, Peng D. Berberine derivatives with different pharmacological activities via structural modifications. Mini Rev Medicinal Chem. 2018;18(17):1424\u201341. https:\/\/doi.org\/10.2174\/1389557517666170321103139.","journal-title":"Mini Rev Medicinal Chem"},{"issue":"8","key":"684_CR13","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/ptr.2399","volume":"22","author":"M Imanshahidi","year":"2008","unstructured":"Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytotherapy Res. 2008;22(8):999\u20131012. https:\/\/doi.org\/10.1002\/ptr.2399.","journal-title":"Phytotherapy Res"},{"key":"684_CR14","doi-asserted-by":"publisher","first-page":"28089","DOI":"10.1038\/srep28089","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, Fu X, Xu J, Wang Q, Kuang H. Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome. Sci Rep. 2016;6:28089. https:\/\/doi.org\/10.1038\/srep28089.","journal-title":"Sci Rep"},{"issue":"1","key":"684_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.fertnstert.2010.07.1090","volume":"95","author":"L Zhao","year":"2011","unstructured":"Zhao L, Li W, Han F, Hou L, Baillargeon JP, Kuang H, Wang Y, Wu X. Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertil Steril. 2011;95(1):461\u20133. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.07.1090.","journal-title":"Fertil Steril"},{"issue":"8","key":"684_CR16","doi-asserted-by":"publisher","first-page":"e42529","DOI":"10.1371\/journal.pone.0042529","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang X, Zhao Y, Zhang M, Pang X, Xu J, Kang C, Li M, Zhang C, Zhang Z, Zhang Y, Li X, Ning G, Zhao L. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One. 2012;7(8):e42529. https:\/\/doi.org\/10.1371\/journal.pone.0042529.","journal-title":"PLoS One"},{"issue":"1","key":"684_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/EJE-11-0616","volume":"166","author":"W Wei","year":"2012","unstructured":"Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012;166(1):99\u2013105. https:\/\/doi.org\/10.1530\/EJE-11-0616.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"684_CR18","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1210\/en.2012-1105","volume":"153","author":"D Abramovich","year":"2012","unstructured":"Abramovich D, Irusta G, Bas D, Cataldi NI, Parborell F, Tesone M. Angiopoietins\/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome. Endocrinology. 2012;153(7):3446\u201356. https:\/\/doi.org\/10.1210\/en.2012-1105.","journal-title":"Endocrinology"},{"key":"684_CR19","doi-asserted-by":"publisher","first-page":"670743","DOI":"10.1155\/2014\/670743","volume":"2014","author":"J Yu","year":"2014","unstructured":"Yu J, Zhai D, Hao L, Zhang D, Bai L, Cai Z, Yu C. Cryptotanshinone reverses reproductive and metabolic disturbances in PCOS model rats via regulating the expression of CYP17 and AR. Evid Based Complement Alternat Med. 2014;2014:670743. https:\/\/doi.org\/10.1155\/2014\/670743.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"684_CR20","doi-asserted-by":"publisher","first-page":"G13","DOI":"10.1530\/JOE-14-0182","volume":"222","author":"JE Bowe","year":"2014","unstructured":"Bowe JE, Franklin ZJ, Hauge-Evans AC, King AJ, Persaud SJ, Jones PM. Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models. J Endocrinol. 2014;222(3):G13\u201325. https:\/\/doi.org\/10.1530\/JOE-14-0182.","journal-title":"J Endocrinol"},{"issue":"7\u20138","key":"684_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.clinbiochem.2012.02.005","volume":"45","author":"RI Coniglio","year":"2012","unstructured":"Coniglio RI, Merono T, Montiel H, Malaspina MM, Salgueiro AM, Otero JC, Ferraris R, Schreier L, Brites F, Gomez Rosso L. HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes. Clin Biochem. 2012;45(7\u20138):566\u201370. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.02.005.","journal-title":"Clin Biochem"},{"key":"684_CR22","doi-asserted-by":"publisher","first-page":"2532935","DOI":"10.1155\/2018\/2532935","volume":"2018","author":"MF Li","year":"2018","unstructured":"Li MF, Zhou XM, Li XL. The effect of Berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): a meta-analysis and systematic review. Evid Based Complement Alternat Med. 2018;2018:2532935. https:\/\/doi.org\/10.1155\/2018\/2532935.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"684_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/01443615.2010.539722","volume":"31","author":"RK Bhathena","year":"2011","unstructured":"Bhathena RK. Insulin resistance and the long-term consequences of polycystic ovary syndrome. J Obstet Gynaecol. 2011;31(2):105\u201310. https:\/\/doi.org\/10.3109\/01443615.2010.539722.","journal-title":"J Obstet Gynaecol"},{"key":"684_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cca.2017.06.009.","volume":"471","author":"SE Karakas","year":"2017","unstructured":"Karakas SE. New biomarkers for diagnosis and management of polycystic ovary syndrome. Clin Chim Acta. 2017;471:248\u201353. https:\/\/doi.org\/10.1016\/j.cca.2017.06.009..","journal-title":"Clin Chim Acta"},{"issue":"3","key":"684_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.4268\/cjcmm20160329","volume":"41","author":"WJ Chen","year":"2016","unstructured":"Chen WJ, Wang FF. Effect of Quyu Huatan decoction on lipid metabolism and hormone levels of patients with polycystic ovary syndrome. Zhongguo Zhong Yao Za Zhi. 2016;41(3):532\u20135. https:\/\/doi.org\/10.4268\/cjcmm20160329.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"4","key":"684_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-0035-1556568","volume":"33","author":"S Shorakae","year":"2015","unstructured":"Shorakae S, Teede H, de Courten B, Lambert G, Boyle J, Moran LJ. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Semin Reprod Med. 2015;33(4):257\u201369. https:\/\/doi.org\/10.1055\/s-0035-1556568.","journal-title":"Semin Reprod Med"},{"issue":"1","key":"684_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12902-018-0243-5","volume":"18","author":"T Tao","year":"2018","unstructured":"Tao T, Wu P, Wang Y, Liu W. Comparison of glycemic control and beta-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment. BMC Endocr Disord. 2018;18(1):14. https:\/\/doi.org\/10.1186\/s12902-018-0243-5.","journal-title":"BMC Endocr Disord"},{"key":"684_CR28","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.12659\/msm.909098","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang Y, He J, Yang J. Eicosapentaenoic acid improves polycystic ovary syndrome in rats via sterol regulatory element-binding protein 1 (SREBP-1)\/toll-like receptor 4 (TLR4) pathway. Med Sci Monitor. 2018;24:2091\u20137. https:\/\/doi.org\/10.12659\/msm.909098.","journal-title":"Med Sci Monitor"},{"issue":"3","key":"684_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.imbio.2010.07.011","volume":"216","author":"S Bhaskar","year":"2011","unstructured":"Bhaskar S, Shalini V, Helen A. Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-kappaB signaling pathway. Immunobiology. 2011;216(3):367\u201373. https:\/\/doi.org\/10.1016\/j.imbio.2010.07.011.","journal-title":"Immunobiology"},{"issue":"10","key":"684_CR30","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1084\/jem.20132496","volume":"211","author":"M Kovacs","year":"2014","unstructured":"Kovacs M, Nemeth T, Jakus Z, Sitaru C, Simon E, Futosi K, Botz B, Helyes Z, Lowell CA, Mocsai A. The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment. J Exp Med. 2014;211(10):1993\u20132011. https:\/\/doi.org\/10.1084\/jem.20132496.","journal-title":"J Exp Med"},{"issue":"7","key":"684_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/1753425915586075","volume":"21","author":"J Toubiana","year":"2015","unstructured":"Toubiana J, Rossi AL, Belaidouni N, Grimaldi D, Pene F, Chafey P, Comba B, Camoin L, Bismuth G, Claessens YE, Mira JP, Chiche JD. Src-family-tyrosine kinase Lyn is critical for TLR2-mediated NF-kappaB activation through the PI 3-kinase signaling pathway. Innate Immunity. 2015;21(7):685\u201397. https:\/\/doi.org\/10.1177\/1753425915586075.","journal-title":"Innate Immunity"},{"issue":"5","key":"684_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1933719116667606","volume":"24","author":"T Li","year":"2017","unstructured":"Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J, Li X, Lu Y. Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci. 2017;24(5):646\u201355. https:\/\/doi.org\/10.1177\/1933719116667606.","journal-title":"Reprod Sci"},{"key":"684_CR33","doi-asserted-by":"publisher","first-page":"111965","DOI":"10.1016\/j.jep.2019.111965","volume":"250","author":"Z Qiu","year":"2020","unstructured":"Qiu Z, Dong J, Xue C, Li X, Liu K, Liu B, Cheng J, Huang F. Liuwei Dihuang pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K\/Akt signaling pathway. J Ethnopharmacol. 2020;250:111965. https:\/\/doi.org\/10.1016\/j.jep.2019.111965.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"684_CR34","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00404-017-4523-5","volume":"296","author":"E Salehi","year":"2017","unstructured":"Salehi E, Aflatoonian R, Moeini A, Yamini N, Asadi E, Khosravizadeh Z, Tarzjani MD, Harat ZN, Abolhassani F. Apoptotic biomarkers in cumulus cells in relation to embryo quality in polycystic ovary syndrome. Arch Gynecol Obstet. 2017;296(6):1219\u201327. https:\/\/doi.org\/10.1007\/s00404-017-4523-5.","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"684_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/1354750X.2016.1265004","volume":"22","author":"H Uyanikoglu","year":"2017","unstructured":"Uyanikoglu H, Sabuncu T, Dursun H, Sezen H, Aksoy N. Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study. Biomarkers. 2017;22(7):643\u20137. https:\/\/doi.org\/10.1080\/1354750X.2016.1265004.","journal-title":"Biomarkers"},{"issue":"3","key":"684_CR36","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3892\/mmr.2018.9793","volume":"19","author":"R Yang","year":"2019","unstructured":"Yang R, Chen J, Wang L, Deng A. LncRNA BANCR participates in polycystic ovary syndrome by promoting cell apoptosis. Mol Med Rep. 2019;19(3):1581\u20136. https:\/\/doi.org\/10.3892\/mmr.2018.9793.","journal-title":"Mol Med Rep"},{"issue":"6","key":"684_CR37","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/jim-2017-000426","volume":"65","author":"L Zheng","year":"2017","unstructured":"Zheng L, Wang W, Ni J, Mao X, Song D, Liu T, Wei J, Zhou H. Role of autophagy in tumor necrosis factor-alpha-induced apoptosis of osteoblast cells. J Investig Med. 2017;65(6):1014\u201320. https:\/\/doi.org\/10.1136\/jim-2017-000426.","journal-title":"J Investig Med"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00684-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-020-00684-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00684-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T02:08:40Z","timestamp":1609985320000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-020-00684-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1186\/s12958-020-00684-y","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"27 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted in strict accordance with the animal ethics standards and with ethics approval from the Ethics Committee of Obstetrics and Gynecology Hospital of Fudan University (no. [2015]45).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}